13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.8M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

AMST Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Amesite Inc. (AMST), a Technology sector company. AMST is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.8m in revenue. Based on the latest XBRL financial filings (Q3 2026), Amesite Inc. reports quarterly revenue of $83.3K, net income of $-678.1K, free cash flow of $-449.2K. Top institutional holders of AMST by reported 13-F value include Focus Partners Wealth, GEODE CAPITAL MANAGEMENT,, STATE STREET, based on the most recent SEC filings. AMST trades on the Nasdaq exchange and files with the SEC under CIK 1807166. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMST daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Amesite Inc. directly from SEC EDGAR.

Revenue

Q3 2026

$83.3K

Net Income

Q3 2026

$-678.1K

Free Cash Flow

Q3 2026

$-449.2K

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-86.9% YoY
$110.5KFY 2025
FY21 $674.6KFY22 $697.0KFY23 $845.0KFY25 $110.5K

Net Income

+12.9% YoY
$-3.6MFY 2025
FY21 $-11.6MFY22 $-9.1MFY23 $-4.2MFY25 $-3.6M

Operating Income

+14.7% YoY
$-3.6MFY 2025
FY21 FY22 $-9.1MFY23 $-4.2MFY25 $-3.6M

EPS (Diluted)

+38.7% YoY
$-1.03FY 2025
FY21 $-0.59FY22 $-4.67FY23 $-1.68FY25 $-1.03

Total Assets

-51.2% YoY
$3.1MFY 2025
FY21 $12.5MFY22 $8.9MFY23 $6.3MFY25 $3.1M

Op. Cash Flow

+24.4% YoY
$-2.5MFY 2025
FY21 $-5.3MFY22 $-6.7MFY23 $-3.2MFY25 $-2.5M

AI Insight: AMST Financial Trends

Amesite remains pre-revenue with consistent $1M quarterly net losses and deteriorating equity from $3M to $1M over eight quarters.

Revenue remains at $0M across all periods Q2 2024–Q1 2026; no commercial traction evident.

Net income and operating income stable at $-1M per quarter; operating cash flow oscillates between $0M and $-1M with no improvement trajectory.

Equity eroded 67% from $3M (Q2 2024) to $1M (Q1 2026), signaling cumulative cash burn without offsetting capital infusions.

Equity now at $1M—critically low runway. Continued $1M quarterly losses imply less than two quarters of self-funding capacity remaining.

No revenue generation over 8 quarters suggests fundamental product-market fit or execution challenges; inflection point unclear.

AI Insight: AMST Ratio Trends

Amesite remains unprofitable with deteriorating returns; Q4 2025 ROE fell to -194.3%, the worst in the dataset.

ROE collapsed to -194.3% in Q4 2025, down from -118.5% in Q3 2025—sharper losses in the latest quarter.

ROA at -99.0% in Q3 2025 shows asset base generating significant negative returns; no improvement trajectory visible.

Q1 2026 data entirely absent; cannot assess whether Q4 2025 deterioration is seasonal or structural.

No operating margin, net profit margin, or debt/equity data available to diagnose root causes of negative returns.

Get alerted when AMST's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Amesite Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put AMST on your watchlist

Track score changes the day Amesite Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AMST a good stock to buy?

13F Pro's AI-powered analysis of Amesite Inc. (AMST) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMST are available on the AMST stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMST?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMST. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Amesite Inc.'s investment landscape.